The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.
Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.
Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.
Tempus AI, Inc. Chief Accounting Officer Ryan M. Bartolucci reported selling 1,904 shares of Class A Common Stock on August 19, 2025 in two sales at $74.63 and $75.61 per share. A footnote explains the shares were sold to cover statutory tax withholding on vested restricted stock units under a mandated “sell to cover” arrangement, not a discretionary sale. After these sales he holds 45,895 shares directly; the trades occurred within a price range of $74.36–$75.2673.
Tempus AI, Inc. insider Erik Phelps submitted a Form 144 notifying a proposed sale of 3,664 shares of Class A common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $287,440.80, and an approximate sale date of 08/19/2025. The filing shows those 3,664 shares were acquired as restricted stock units on 04/18/2023 (371 shares), 07/18/2023 (2,470 shares) and 05/02/2024 (823 shares), which sum to the shares offered for sale. The filing also discloses prior sales by the same person in the last three months: 8,415 shares sold on 05/20/2025 for $531,918.03 and 51,317 shares sold on 06/16/2025 for $3,723,602.63. The Form 144 includes the required certification that the seller is not aware of undisclosed material adverse information.
Tempus AI, Inc. (TEM) Form 144 shows proposed sale of 5,398 Class A common shares through Morgan Stanley Smith Barney LLC on 08/19/2025 with an aggregate market value of $423,473.10. The filing identifies the shares as originating from restricted stock units issued between 04/27/2022 and 05/02/2024 totaling 5,398 shares. Recent sales by the same person, Andrew Polovin, are disclosed: total sales of 9,797 shares on 05/20/2025 for $619,275.23, 10b5-1 sales of 7,755 shares on 05/20/2025 for $494,085.01, and 1,423 shares on 06/16/2025 for $102,640.99. The filer certifies no undisclosed material adverse information and notes potential use of a 10b5-1 plan.
Tempus AI, Inc. (TEM) submitted a Form 144 disclosing a proposed sale of 17,460 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,369,737, and an approximate sale date of 08/19/2025 on NASDAQ. Those shares reflect restricted stock units acquired from the issuer on 01/03/2022 (1,746), 04/18/2023 (583), 07/18/2023 (5,820), and 08/01/2024 (9,311), totaling 17,460 shares. The filer also reported insider sales in the past three months totaling 32,820 shares for $2,040,116.11, including a 10b5-1 plan sale of 20,000 shares on 06/03/2025. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Tempus AI, Inc. (TEM) filing a Form 144 notifies the market of a proposed sale of 17,458 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value reported as $1,369,580.10 and an approximate sale date of 08/19/2025 on Nasdaq. The shares were acquired as restricted stock units on 06/13/2024. The filing also lists prior sales in the past three months by related parties and individuals, including Eric P. Lefkofsky and entities Blue Media, LLC and Gray Media, LLC, totaling significant share volumes and gross proceeds across dates from 05/20/2025 to 07/28/2025.
Tempus AI, Inc. insider filings show a proposed sale of 7,528 Class A common shares through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $590,571.60. The shares were granted as restricted stock units between 04/21/2021 and 05/02/2024 in multiple tranches totaling the amounts listed. The filer previously sold 23,121 shares under a 10b5-1 plan on 05/20/2025 for gross proceeds of $1,462,779.51. The notice includes the standard signature representation that no undisclosed material adverse information is known.
Tempus AI insider Ryan M. Bartolucci filed a Form 144 notifying intent to sell 1,904 shares of Class A common stock through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $149,368.80. The proposed sale date listed is 08/19/2025 and the issuer's outstanding shares are reported as 168,683,769.
The shares to be sold were issued as restricted stock units on four dates (07/14/2021, 04/27/2022, 04/18/2023 and 05/02/2024) totaling 1,904 shares. The filing also discloses a prior sale by the same person of 6,073 Class A shares on 05/20/2025 for gross proceeds of $384,022.79. The filer certifies no undisclosed material adverse information.
Tempus AI's definitive information statement discloses amended articles with marked changes included as Appendix A-2 and references a securities description in Exhibit 4.3. The document shows a holder with 40,601,284 Class A shares (24.1%) and 5,043,789 Class B shares (100.0%) representing 60.0% combined voting power. The articles require a two-thirds plus one (66 2/3%) vote of outstanding voting power to alter Articles V, VI and VII.
Tempus AI, Inc. (TEM) submitted a Form 144 notice to report a proposed sale of 44,000 shares of common stock through Citigroup Global Markets Inc., with an aggregate market value of $3,075,786.12. The filing lists the approximate sale date as 08/13/2025 and the shares are expected to trade on NASDAQ. The shares were acquired on 01/30/2025 as a venture capital distribution from Revolution Growth III, totalling 130,756 shares received on that date. The filer reports no sales of the issuer's securities in the past three months. Certain filer identification fields (CIK/CCC and contact details) are not provided in the visible content.
Theodore J. Leonsis, a director of Tempus AI, Inc. (TEM), reported a sale of Class A common stock on 08/13/2025. The filing shows 44,000 shares disposed of at a reported price of $69.90 per share. After the transaction the report lists 86,756 shares held indirectly through the Theodore J. Leonsis Revocable Trust and 15,511 shares held directly by the reporting person. The form notes that certain shares were recharacterized following pro rata distributions by Revolution Growth GP III, LP, which changed the form of ownership but did not involve consideration. The filing was signed by an attorney-in-fact on 08/15/2025.